Sign Up Today and Learn More About Kwivik Therapeutics Inc Stock
Invest in or calculate the value of your shares in Kwivik Therapeutics Inc or other pre-IPO companies through EquityZen's platform.
About Kwivik Therapeutics Inc Stock
Founded
2016
Headquarters
Frisco, TX, US
Total Funding
50.0M
Industries
Software, Artificial Intelligence, Data and Analytics
Kwivik Therapeutics Inc. is a pre-IPO medtech company that has developed a way to create medical oxygen from two, dry inert powders. The oxygen is created on demand, without the need for pressurized storage. We combined this "oxygen from powder" technology with innovative biotech, engineering, IoT and AI technologies to develop a robust pipeline of products to disrupt certain respiratory, emergency medical, asthma, cluster headache/migraine, wound care and skin care markets globally, with a combined market size exceeding $750 Billion.
Kwivik Therapeutics Inc Press Mentions
Stay in the know about the latest news on Kwivik Therapeutics Inc
Kwivik Therapeutics Receives Market Clearance for O2Ventilate in India
ca • Jul 07, 2021
Kwivik Therapeutics Partners with EirMed to Accelerate Product Commercialization
finance • Jan 13, 2021
Largest players in MedTech industry embrace artificial intelligence
Medical Device Network • Jan 04, 2021
Brexit deal creates regulatory barriers to UK-EU medical device trade
MedTech Dive • Jan 04, 2021
How Medtech Is Reshaping Continuing Education In The Medical Profession
Forbes • Dec 31, 2020
Investors in Kwivik Therapeutics Inc
Discover investors in Kwivik Therapeutics Inc stock and explore their portfolio companies
Kwivik Therapeutics Inc Management
Leadership team at Kwivik Therapeutics Inc
Chief Executive Officer
Julian Ross, MBA
Chief Financial Officer
Jeff Robertson, CPA, CGMA
Join now and verify your accreditation status to gain access to:
- Kwivik Therapeutics Inc current valuation
- Kwivik Therapeutics Inc stock price
- Available deals in Kwivik Therapeutics Inc and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Kwivik Therapeutics Inc Stock
How to invest in Kwivik Therapeutics Inc stock?
Accredited investors can buy pre-IPO stock in companies like Kwivik Therapeutics Inc through EquityZen funds. These investments are made available by existing Kwivik Therapeutics Inc shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Kwivik Therapeutics Inc stock?
Shareholders can sell their Kwivik Therapeutics Inc stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
